4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000016
President and CEO acquired 226,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Brunn Carsten · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 1 in the form | +226,300 | 531,555 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-03 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +1,056,100 | 1,056,100 | D |
Loading xslF345X03/wf-form4_164141830853581.xml…